Roche Holding AG

Research Roche Holding AG (RO) on Bullrun: market cap CHF 263.35B, P/E 20.6, dividend yield 3.0%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerRO
• ExchangeSW
• CountrySwitzerland
• SectorHealthcare
• IndustryDrug Manufacturers - General
• CurrencyCHF
• Market capCHF 263.35B
• P/E20.6
• Dividend yield3.0%
• Financial periodFY2025
• RevenueCHF 63.36B
• Revenue growth1.5%
• Net incomeCHF 12.88B
• Free cash flowCHF 13.07B
• Gross margin73.7%

Valuation Snapshot

latest market cap is CHF 263.35B; P/E is 20.6; dividend yield is 3.0%.

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.

Frequently asked questions

What is Roche Holding AG's market cap?

Roche Holding AG's market capitalization is CHF 263.35B.

What is Roche Holding AG's P/E ratio?

Roche Holding AG's price-to-earnings (P/E) ratio is 20.6.

Does Roche Holding AG pay a dividend?

Roche Holding AG has a dividend yield of 3.0%.

What does Roche Holding AG do?

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.